Back to the Top
The following message was posted to: PharmPK
Dear All
Suppose I have done full validation of any drug in rat plasma, now I
need to do partial validation in dog plasma.
I HAVE A QUESTION :
Do I need to do dilution integrity in dog plasma also, what fda
accepts
I would appreciate if I can get references for the same
Thanks in advance
Priyadeep bhutani
Back to the Top
The following message was posted to: PharmPK
1) How much risk are you willing to assume?
A) Is the recovery the same?
B) Are the interferences the same (See E, below)
C) Is the stability the same?
D) Is the dilutional linearity the same?
E) Is the LLOQ the same?
2) If you are willing to assume a great deal of risk, a partial
validation would seem to save money and time. Be advised though, that
you may encounter some difficulty which will cost you time and money
later. Some of the difficulty would be in answering why you chose to
make the assumptions you did a priori.
3) It is better to run a full validation of the second species rather
than run the risk of failing one or more!
--
Ed O'Connor, Ph.D.
Laboratory Director
Matrix BioAnalytical Laboratories
25 Science Park at Yale
New Haven, CT 06511
Web: www.matrixbioanalytical.com
Email: eoconnor.aaa.matrixbioanalytical.com
Back to the Top
Dear Priyadeep,
In this case, I usually validate the dilution for every species tested.
Best regards,
gilles
Back to the Top
There is no room for partial revalidation where you do any validation
or revalidation it should be Complete
Particularly where you want ultimately the results to be published.
However in a situation where you are doing research not for serious
purposes it is okay.
s.o.o
Back to the Top
Dear Priyadeep,
I offer my comments regarding the question of partial validation or
full validation for a second species (or in other words, what level
of validation to perform with the second species?).
Unless you have extensive experience with the analyte in the two
species and can be very sure that the performance and range will be
the same, I would recommend full validation. However, stability of
the stock solutions need not be retested if the same concentration is
used.
I have seen many cases in which an assay in dog plasma performed
differently from the one in rat plasma. Better to determine this up
front than to run an abbreviated validation and find that there are
assay problems when you analyze study samples.
After you perform 2 animal species and a human validation and find
all to be similar and predictable, I would be willing to consider a
partial validation for the next species (same matrix).
-Tom
Thomas L. Tarnowski, Ph.D.
Bioanalytical Development
Elan Pharmaceuticals, Inc.
800 Gateway Boulevard
South San Francisco, CA 94080
thomas.tarnowski.at.elan.com
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Assay revalidation" as the subject | Support PharmPK by using the |
Copyright 1995-2011 David W. A. Bourne (david@boomer.org)